TY - JOUR
T1 - TRPA1 Inhibition Effects by 3-Phenylcoumarin Derivatives
AU - Sallomy, Carita
AU - Awolade, Paul
AU - Rahnasto-Rilla, Minna
AU - Hämäläinen, Mari
AU - Nousiainen, Liisa P.
AU - Johansson, Niklas G.
AU - Hiltunen, Sanna
AU - Turhanen, Petri
AU - Moilanen, Eeva
AU - Lahtela-Kakkonen, Maija
AU - Timonen, Juri M.
N1 - Publisher Copyright:
© 2024 American Chemical Society.
PY - 2024/7/2
Y1 - 2024/7/2
N2 - Transient receptor potential ankyrin 1 (TRPA1) protein plays an important role in the inflammatory response, and it has been associated with different pain conditions and pain-related diseases, making TRPA1 a valid target for painkillers. In this study, we identified potential TRPA1 inhibitors and located their binding sites utilizing computer-aided drug design (CADD) techniques. The designed 3-phenylcoumarin-based TRPA1 inhibitors were successfully synthesized using a microwave assisted synthetic strategy. 3-(3-Bromophenyl)-7-acetoxycoumarin (5), 7-hydroxy-3-(3-hydroxyphenyl)coumarin (12) and 3-(3-hydroxyphenyl)coumarin (23) all showed inhibitory activity toward TRPA1 in vitro. Compound 5 also decreased the size and formation of breast cancer cells. Hence, targeting TRPA1 may represent a promising alternative for the treatment of pain and inflammation.
AB - Transient receptor potential ankyrin 1 (TRPA1) protein plays an important role in the inflammatory response, and it has been associated with different pain conditions and pain-related diseases, making TRPA1 a valid target for painkillers. In this study, we identified potential TRPA1 inhibitors and located their binding sites utilizing computer-aided drug design (CADD) techniques. The designed 3-phenylcoumarin-based TRPA1 inhibitors were successfully synthesized using a microwave assisted synthetic strategy. 3-(3-Bromophenyl)-7-acetoxycoumarin (5), 7-hydroxy-3-(3-hydroxyphenyl)coumarin (12) and 3-(3-hydroxyphenyl)coumarin (23) all showed inhibitory activity toward TRPA1 in vitro. Compound 5 also decreased the size and formation of breast cancer cells. Hence, targeting TRPA1 may represent a promising alternative for the treatment of pain and inflammation.
KW - computational modeling
KW - neuropathic pain
KW - phenylcoumarin
KW - TRPA1
KW - 116 Chemical sciences
U2 - 10.1021/acsmedchemlett.4c00072
DO - 10.1021/acsmedchemlett.4c00072
M3 - Article
SN - 1948-5875
JO - ACS Medicinal Chemistry Letters
JF - ACS Medicinal Chemistry Letters
ER -